切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-alpha Reductases - EZH2 - Inward Rectifier Potassium (Kir) Channels - GABAA Receptors

15件产品中的 1-10

页面
每页
清除全部
  1. CPI-169
    B4678 CPI-169
     1 Citation
    Target: EZH2|EZH1
    Summary: EZH2抑制剂
      ≥26.45 mg/mL
      insoluble in H2O
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. UNC1999
    B1583 UNC1999
     2 Citation
    Target: EZH2|EZH1
    Summary: EZH2抑制剂
      ≥28.5 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. Furosemide
    A8435 Furosemide
    中文名: 呋塞米
    Target: Na /K /Cl- Symporters (NKCCs)|GABAA Receptors
    Summary: GABAA受体拮抗剂
      ≥14.9 mg/mL
      insoluble in H2O
  9. Dutasteride
    A1659 Dutasteride
    中文名: 度他雄胺
    Target: 5-alpha Reductases
    Summary: 5-alpha-还原酶抑制剂
      ≥26.43 mg/mL
      ≥13.75 mg/mL
  10. Flumazenil
    A2917 Flumazenil
    中文名: 氟马西尼
    Target: GABAA Receptors
    Summary: 苯二氮卓拮抗剂
      ≥30.38 mg/mL
      insoluble in H2O

15件产品中的 1-10

页面
每页